Comment from Battelle Memorial Institute

Summary: Battelle Memorial Institute, a contract research organization (CRO), supports the FDA's draft guidance on New Approach Methodologies (NAMs) in drug development. They request additional practical examples, clearer operational details on the "fit-for-purpose" framework, and more explicit guidance on how NAM data will be integrated into regulatory decision-making.